Citadel Advisors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.44M | Buy |
543,196
+353,519
| +186% | +$4.84M | ﹤0.01% | 1580 |
|
2025
Q1 | $2.1M | Sell |
189,677
-39,108
| -17% | -$433K | ﹤0.01% | 2552 |
|
2024
Q4 | $2.44M | Sell |
228,785
-13,281
| -5% | -$141K | ﹤0.01% | 2403 |
|
2024
Q3 | $3.07M | Buy |
242,066
+167,704
| +226% | +$2.13M | ﹤0.01% | 2140 |
|
2024
Q2 | $1.25M | Buy |
74,362
+2,546
| +4% | +$42.7K | ﹤0.01% | 2839 |
|
2024
Q1 | $1.08M | Sell |
71,816
-72,063
| -50% | -$1.08M | ﹤0.01% | 3109 |
|
2023
Q4 | $2.16M | Buy |
143,879
+136,883
| +1,957% | +$2.05M | ﹤0.01% | 2329 |
|
2023
Q3 | $98K | Sell |
6,996
-40,984
| -85% | -$574K | ﹤0.01% | 4851 |
|
2023
Q2 | $497K | Sell |
47,980
-29,196
| -38% | -$302K | ﹤0.01% | 3650 |
|
2023
Q1 | $713K | Buy |
77,176
+28,239
| +58% | +$261K | ﹤0.01% | 3507 |
|
2022
Q4 | $434K | Buy |
48,937
+35,216
| +257% | +$312K | ﹤0.01% | 3991 |
|
2022
Q3 | $114K | Buy |
+13,721
| New | +$114K | ﹤0.01% | 5066 |
|
2021
Q4 | – | Sell |
-57,298
| Closed | -$964K | – | 7220 |
|
2021
Q3 | $964K | Sell |
57,298
-11,251
| -16% | -$189K | ﹤0.01% | 3821 |
|
2021
Q2 | $1.05M | Buy |
68,549
+30,604
| +81% | +$467K | ﹤0.01% | 3967 |
|
2021
Q1 | $739K | Buy |
37,945
+1,619
| +4% | +$31.5K | ﹤0.01% | 4226 |
|
2020
Q4 | $655K | Buy |
36,326
+11,367
| +46% | +$205K | ﹤0.01% | 3635 |
|
2020
Q3 | $481K | Buy |
24,959
+3,966
| +19% | +$76.4K | ﹤0.01% | 3533 |
|
2020
Q2 | $548K | Sell |
20,993
-47,285
| -69% | -$1.23M | ﹤0.01% | 3384 |
|
2020
Q1 | $1.22M | Sell |
68,278
-5,405
| -7% | -$96.4K | ﹤0.01% | 2673 |
|
2019
Q4 | $2.46M | Sell |
73,683
-21,128
| -22% | -$705K | ﹤0.01% | 2169 |
|
2019
Q3 | $2.26M | Sell |
94,811
-6,994
| -7% | -$167K | ﹤0.01% | 2271 |
|
2019
Q2 | $3.66M | Sell |
101,805
-67,844
| -40% | -$2.44M | ﹤0.01% | 1901 |
|
2019
Q1 | $6.27M | Sell |
169,649
-204,683
| -55% | -$7.56M | ﹤0.01% | 1425 |
|
2018
Q4 | $16.1M | Buy |
374,332
+98
| +0% | +$4.22K | 0.01% | 773 |
|
2018
Q3 | $17.7M | Buy |
374,234
+53,200
| +17% | +$2.51M | 0.01% | 809 |
|
2018
Q2 | $16M | Buy |
321,034
+239,676
| +295% | +$11.9M | 0.01% | 819 |
|
2018
Q1 | $4.04M | Buy |
+81,358
| New | +$4.04M | ﹤0.01% | 1409 |
|